Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agilent; Thermo Fisher Scientific; Lexogen; Coriell Institute for Medical Research; Global Genomics Group

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has inked a partnership with South Korea's Center for Women in Science, Engineering and Technology to help advance women scientists and engineers in that country. The partners will jointly develop training programs that will be conducted at WISET's academy and at Agilent's customer applications and training center in Seoul. The training will be conducted by Agilent employees for groups of unemployed women identified by WISET.

Thermo Fisher Scientific is seeking a buyer for its Cole-Parmer Instrument business, according to a report from Bloomberg this week, and could fetch between $500 million and $700 million. The Cole-Parmer business was purchased by Fisher Scientific for $205 million in 2001, long before Fisher merged with Thermo Electron in 2006.

Austrian biotech firm Lexogen GmbH has opened its North American subsidiary Lexogen Inc., located in New Hampshire and staffed for supply chain management and customer support for RNA and transcriptome-related products. Lexogen GmbH develops technologies for complete transcriptome sequencing.

The Coriell Institute for Medical Research has received a $1 million grant from the William G. Rohrer Charitable Foundation that the institute will use to bolster its laboratories and induced pluripotent stem cell infrastructure. Coriell has cultivated, stored, and distributed more than 77 cell lines, including models of type 1 diabetes, muscular dystrophy, Huntington's disease, and more, the Camden, NJ-based institute said.

Global Genomics Group said it has completed enrollment of 7,500 patients for its prospective Genetic Loci and Burden of Atherosclerotic Lesions (GLOBAL) study, a pan-omic study aimed at identifying disease-related pathways, new drug targets, and biomarkers of cardiovascular diseases. The study will collect 22 trillion data points from the 7,500 patients, the firm said. Global Genomics Group had previously announced collaborations with Caprion Proteomics, Quintiles, and Metabolon for GLOBAL.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.